Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Rech

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|February 17, 2017
T-Cell Transfer Therapy Targeting Mutant KRASAndrew J Rech, Robert H Vonderheide
Cancer Discovery|December 12, 2013
Dynamic interplay of oncogenes and T cells induces PD-L1 in the tumor microenvironmentAndrew J Rech, Robert H Vonderheide
Annals of the New York Academy of Sciences|September 23, 2009
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cellsAndrew J Rech, Robert H Vonderheide
Cell Systems|October 14, 2019
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint BlockadeLee P Richman, Robert H Vonderheide, Andrew J Rech
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2016
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic CancerDavid Balli, Andrew J Rech, Ben Z Stanger, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2009
Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancerAndrew J Rech, Rosemarie Mick, David E Kaplan, et al.
Cancer Immunology Research|January 18, 2018
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human CancerAndrew J Rech, David Balli, Alejandro Mantero, et al.
Cancer Research|May 31, 2018
Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in CancerAndrew J Rech, Hannah Dada, Jonathan J Kotzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2017
Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiencyRoberto Calcedo, Suryanarayan Somanathan, Qiuyue Qin, et al.
Frontiers in Immunology|October 10, 2022
A real-time GPU-accelerated parallelized image processor for large-scale multiplexed fluorescence microscopy dataGuolan Lu, Marc A Baertsch, John W Hickey, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|February 17, 2017
T-Cell Transfer Therapy Targeting Mutant KRASAndrew J Rech, Robert H Vonderheide
Cancer Discovery|December 12, 2013
Dynamic interplay of oncogenes and T cells induces PD-L1 in the tumor microenvironmentAndrew J Rech, Robert H Vonderheide
Annals of the New York Academy of Sciences|September 23, 2009
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cellsAndrew J Rech, Robert H Vonderheide
Cell Systems|October 14, 2019
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint BlockadeLee P Richman, Robert H Vonderheide, Andrew J Rech
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2016
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic CancerDavid Balli, Andrew J Rech, Ben Z Stanger, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2009
Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancerAndrew J Rech, Rosemarie Mick, David E Kaplan, et al.
Cancer Immunology Research|January 18, 2018
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human CancerAndrew J Rech, David Balli, Alejandro Mantero, et al.
Cancer Research|May 31, 2018
Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in CancerAndrew J Rech, Hannah Dada, Jonathan J Kotzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2017
Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiencyRoberto Calcedo, Suryanarayan Somanathan, Qiuyue Qin, et al.
Frontiers in Immunology|October 10, 2022
A real-time GPU-accelerated parallelized image processor for large-scale multiplexed fluorescence microscopy dataGuolan Lu, Marc A Baertsch, John W Hickey, et al.
Pageof 3